As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/16/24  BioRestorative Therapies, Inc.    NT 10-Q     3/31/24    1:23K                                    Certilman Balin … LLP/FA 
 4/19/24  BioRestorative Therapies, Inc.    424B3                  1:173K                                   Certilman Balin … LLP/FA 
 4/18/24‡ BioRestorative Therapies, Inc.    EFFECT      4/18/24    1:2K                                     SEC #5                   
 4/17/24  BioRestorative Therapies, Inc.    CORRESP¶    5/16/24    1:7K                                     Certilman Balin … LLP/FA 
 4/12/24  BioRestorative Therapies, Inc.    S-1/A                  1:86K                                    Certilman Balin … LLP/FA 
 4/11/24  SEC                               UPLOAD¶     5/16/24    2:39K  BioRestorative Therapies, Inc.                             
 4/10/24  Silva Francisco                   4          Dir.,Off.²  1:14K  BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
  4/3/24  BioRestorative Therapies, Inc.    S-1                    4:339K                                   Certilman Balin … LLP/FA 
  4/1/24‡ BioRestorative Therapies, Inc.    10-K       12/31/23   80:9M                                     M2 Compliance LLC/FA     
 3/20/24  Silva Francisco                   4          Dir.,Off.²  1:12K  BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 3/20/24  Alstodt Lance                     4          Dir.,Off.²  1:8K   BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 3/12/24  BioRestorative Therapies, Inc.    8-K:7,9     3/11/24   12:21M                                    Certilman Balin … LLP/FA 
  3/6/24  Broadrick Dale                    SC 13D/A               1:51K  BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Silva Francisco                   SC 13D/A               2:78K  BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Alstodt Lance                     SC 13D/A               2:79K  BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Rosa David A                      4          Director²   1:6K   BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Williams Patrick F.               4          Director²   1:6K   BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Kukekov Nickolay V.               4          Director²   1:6K   BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Paccasassi Robert                 4          Officer²    1:6K   BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 
 2/15/24  Kristal Robert Eugene             4          Officer²    1:7K   BioRestorative Therapies, Inc.    Certilman Balin … LLP/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	424B3	Prospectus – New Facts or Events.
	CORRESP	Comment-Response or Other Letter to the SEC.
	EFFECT	SEC Notice of Effectiveness.
	NT 10-Q	Notice of a Late Filing of a Form 10-Q Quarterly Report — Form 12b-25.
	S-1	Registration Statement (General Form) — Form S-1.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	UPLOAD	Comment or Other Letter from the SEC.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
	¶	This Filing contains a delayed-release Document.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.